当前位置:
X-MOL 学术
›
Eur. Respir. J.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Response from the authors: As-needed ICS/formoterol or as-needed SABA in mild asthma?
European Respiratory Journal ( IF 24.3 ) Pub Date : 2024-04-04 , DOI: 10.1183/13993003.00395-2024 Alberto Papi , Diogenes S. Ferreira , Thomy Tonia , Florence Schleich
Extract
中文翻译:
作者的回应:轻度哮喘需要按需使用 ICS/福莫特罗还是按需使用 SABA?
提炼
更新日期:2024-04-04
European Respiratory Journal ( IF 24.3 ) Pub Date : 2024-04-04 , DOI: 10.1183/13993003.00395-2024 Alberto Papi , Diogenes S. Ferreira , Thomy Tonia , Florence Schleich
We thank J.A. Krishnan and R. Buhl for their commentary on our document "European Respiratory Society short guidelines for the use of as-needed ICS/formoterol in mild asthma", which was published in this journal in October 2023 [1]. We appreciate their willingness in building trust in the guideline development process.
中文翻译:
作者的回应:轻度哮喘需要按需使用 ICS/福莫特罗还是按需使用 SABA?
我们感谢 JA Krishnan 和 R. Buhl 对我们的文件“欧洲呼吸学会在轻度哮喘中使用按需 ICS/福莫特罗的简短指南”的评论,该文件于 2023 年 10 月在本杂志上发表[1]。我们感谢他们愿意在指南制定过程中建立信任。